Amgen Stock Beats S&P 500 with High Dividend Performance
Amgen Stock Performance
Dividend investing can be a profitable strategy for traders, providing an extra source of income alongside potential stock gains. Amgen has demonstrated strong performance, surpassing the average return of the S&P 500.
Earnings and Dividend Yield
AMGN shares have outperformed the S&P 500, with a return of 382.28% compared to the index's 292.76%. Regarding dividends, Amgen offers an attractive annualized yield of 3.39%, exceeding the S&P 500 companies' average yield.
MariTide Potential
MariTide, a weight loss treatment candidate by Amgen, could drive substantial revenues with estimated peak sales of up to $4 billion annually. Amgen's stock is expected to yield positive returns due to its diversified portfolio and dividend program.
Conclusion
Amgen's shares offer a relatively low-risk opportunity for growth, appealing to investors seeking market-beating returns over the long term.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.